CA2017269A1 - Benzoxazole fluorogenique - Google Patents

Benzoxazole fluorogenique

Info

Publication number
CA2017269A1
CA2017269A1 CA2017269A CA2017269A CA2017269A1 CA 2017269 A1 CA2017269 A1 CA 2017269A1 CA 2017269 A CA2017269 A CA 2017269A CA 2017269 A CA2017269 A CA 2017269A CA 2017269 A1 CA2017269 A1 CA 2017269A1
Authority
CA
Canada
Prior art keywords
fluorogenic
substituted
radical
benzoxazoles
fluorogenic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2017269A
Other languages
English (en)
Other versions
CA2017269C (fr
Inventor
Klaus Habenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of CA2017269A1 publication Critical patent/CA2017269A1/fr
Application granted granted Critical
Publication of CA2017269C publication Critical patent/CA2017269C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/805—Test papers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002017269A 1989-05-23 1990-05-22 Benzoxazole fluorogenique Expired - Fee Related CA2017269C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3916729.1 1989-05-23
DE3916729A DE3916729A1 (de) 1989-05-23 1989-05-23 Fluorogene verbindungen und ihre verwendung

Publications (2)

Publication Number Publication Date
CA2017269A1 true CA2017269A1 (fr) 1990-11-23
CA2017269C CA2017269C (fr) 2001-01-09

Family

ID=6381211

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002017269A Expired - Fee Related CA2017269C (fr) 1989-05-23 1990-05-22 Benzoxazole fluorogenique

Country Status (6)

Country Link
US (3) US5585247A (fr)
EP (1) EP0399409A3 (fr)
JP (1) JP2997506B2 (fr)
AU (1) AU628566B2 (fr)
CA (1) CA2017269C (fr)
DE (1) DE3916729A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3830623B2 (ja) 1997-07-14 2006-10-04 株式会社半導体エネルギー研究所 結晶性半導体膜の作製方法
US6140051A (en) * 1997-07-21 2000-10-31 Promega Biosciences, Inc. Fluorescent dibenzazole derivatives and methods related thereto
WO2000004007A1 (fr) * 1998-07-17 2000-01-27 Promega Biosciences, Inc. Derives de dibenzazole fluorescents et procedes concernant ces derives
EP1100520B1 (fr) 1998-07-21 2004-09-22 Cytovia, Inc. Nouveaux colorants fluorescents et leurs applications dans des methodes de criblage par fluorescence de cellules entieres pour des caspases, peptidases, proteases et autres enzymes ainsi que leurs procedes d' utilisation
DE19954934A1 (de) * 1999-11-16 2001-05-17 Otto S Wolfbeis Verfahren zur Solubilisierung von optischen Markern
US6348324B1 (en) 1999-01-21 2002-02-19 Hypoguard America Limited Composition and device for detecting leukocytes in urine
US6528652B1 (en) 1999-01-21 2003-03-04 Chronimed Composition and device for detecting leukocytes in urine
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6783968B2 (en) * 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6800472B2 (en) 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
RU2371440C2 (ru) * 2004-05-20 2009-10-27 Дзе Скриппс Рисёч Инститьют Стабилизация транстиретина
WO2006022194A1 (fr) * 2004-08-23 2006-03-02 Semiconductor Energy Laboratory Co., Ltd. Composition d’injection électronique, et élément luminescent et dispositif luminescent utilisant la composition d’injection électronique
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
JP5540640B2 (ja) 2009-10-07 2014-07-02 住友化学株式会社 複素環化合物及びその有害節足動物防除用途
US10105706B2 (en) * 2010-01-19 2018-10-23 Becton, Dickinson And Company Container assembly and system for detection thereof
DE102013111378A1 (de) 2013-10-15 2015-04-16 Marabu Gmbh & Co. Kg Verfahren zur Dekoration von Substraten sowie dekoriertes Substrat
CN113801179B (zh) * 2020-06-11 2025-10-31 华东理工大学 一类β-半乳糖苷酶荧光探针、制备方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929115A1 (de) * 1979-07-18 1981-02-12 Boehringer Mannheim Gmbh Verfahren zur herstellung von luciferin
AU6617881A (en) * 1981-01-13 1982-07-22 Usv Pharmaceutical Corp. Heterocyclic compounds useful as anti-allergy agents
JPS58129995A (ja) * 1982-01-26 1983-08-03 Fuji Photo Film Co Ltd β−ガラクトシダ−ゼ活性測定方法
AU558939B2 (en) * 1982-03-03 1987-02-12 British Technology Group Limited Enhanced luminescent and luminometric assay
DE3248043A1 (de) * 1982-12-24 1984-06-28 Bayer Ag, 5090 Leverkusen Fluorogene phosphorsaeureester, verfahren zu deren herstellung sowie verfahren und mittel zum nachweis und zur fluorometrischen bestimmung von phosphaten
DE3329394A1 (de) * 1983-08-13 1985-02-28 Bayer Ag, 5090 Leverkusen Chromogene und fluorogene carbonsaeureester, verfahren zu deren herstellung sowie verfahren und mittel zum nachweis und zur bestimmung von hydrolasen
US4708933A (en) * 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
US4950588A (en) * 1985-07-10 1990-08-21 Molecular Diagnostics, Inc. Prolonged enhanced chemiluminescence
DE3537877A1 (de) * 1985-10-24 1987-04-30 Geiger Reinhard Luciferin-derivate und immunoassays unter einsatz derartiger luciferin-derivate
AU6418986A (en) * 1985-11-15 1987-05-21 John Edward Commerford Demountable and portable staging/platform system
DE3732871A1 (de) * 1987-09-30 1989-04-20 Behringwerke Ag Chromogene substrate
JP3169216B2 (ja) * 1988-07-08 2001-05-21 プロメガ・バイオサイエンシーズ・インコーポレイテッド 蛍光性ベンゾチアゾール誘導体の製法及び用途
JPH05129995A (ja) * 1991-10-31 1993-05-25 Nec Corp 受信ｓｄ方式及び受信装置

Also Published As

Publication number Publication date
US5696001A (en) 1997-12-09
EP0399409A2 (fr) 1990-11-28
JPH0311071A (ja) 1991-01-18
US5648229A (en) 1997-07-15
CA2017269C (fr) 2001-01-09
EP0399409A3 (fr) 1991-05-08
AU5573390A (en) 1990-11-29
JP2997506B2 (ja) 2000-01-11
AU628566B2 (en) 1992-09-17
US5585247A (en) 1996-12-17
DE3916729A1 (de) 1990-12-06

Similar Documents

Publication Publication Date Title
CA2017269A1 (fr) Benzoxazole fluorogenique
FI971489A0 (fi) Uusia bentsoksatsoleja
ES2124167A1 (es) Nuevos derivados del bencimidazol con actividad antihistaminica.
AU5428486A (en) Phenyl carbamates
AU3670100A (en) Catalyst for production of acetic acid or acetic acid and ethyl acetate, processfor its production and process for production of acetic acid or acetic acid and ethyl acetate using it
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
PL298988A1 (en) Novel derivatives of acetic acod, pharmaceutical preparation, method of obtaining such derivatives and method of obtaining initial compounds
NO20002595D0 (no) Anvendelse av en ringsystemforbindelse for fremstilling av et medikament
NO965339D0 (no) Fraksjonerte, polydisperse blandinger
AU2001255533A1 (en) Alkene oligomerization process
NO982987D0 (no) Amidinoproteasehemmere
ATE255568T1 (de) Isothiazolcarbonsäureamide
CA2037975A1 (fr) Analogues du 5-hydroxy-2,3-dihydrobenzofurane comme inhibiteurs de la biosynthese des leucotrienes
RU92016490A (ru) Новые 2-сахаринилметил(арил и арокси)ацетаты, применимые в качестве ингибиторов протеолитических ферментов, их композиции и способ их применения
ATE240339T1 (de) Nukleotidanaloga
DK0696319T3 (da) Enzym, der udviser pectinmethylesterase-aktivitet
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
CA2126752A1 (fr) Benzopyrane et antagonistes apparentes du ltb4
EA199800189A1 (ru) Оптически активное производное фенилпиримидина в качестве анальгетика
NO981393D0 (no) Guanidinoproteasehemmere
EE04345B1 (et) Simvastatiini ja selle derivaatide valmistamise protsess
EA199900812A1 (ru) Производные циклопентенона
AU2383697A (en) Use of aspartic acid-containing polymers in cooling circuits with added biocides
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
CA2046485A1 (fr) Agent inhibiteur de la tyrosinase

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed